Crossmark

Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms

Published Online: 2020-05-27

Published Print: 2021-02

Authors

Tay, Rong En http://orcid.org/0000-0003-3647-9271
Richardson, Emma K.

Toh, Han Chong
License Information

Text and Data Mining valid from 2020-05-27

Version of Record valid from 2020-05-27
More Information

Article History

Received: 27 February 2020

Revised: 4 May 2020

Accepted: 12 May 2020

First Online: 27 May 2020

Compliance with ethical standards

:

: H.C.T. is the Chief Medical Officer of Tessa Therapeutics Limited.

Document is current